Research programme: cancer therapeutics - Viridis Biotech
Latest Information Update: 28 Jul 2018
At a glance
- Originator Medical Marijuana Sciences
- Developer University of Northern Colorado; Viridis Biotech
- Class Cannabinoids; Cell therapies
- Mechanism of Action Cell replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Brain cancer; Pancreatic cancer
Most Recent Events
- 28 Jul 2018 No recent reports of development identified for preclinical development in Brain-cancer in USA
- 28 Jul 2018 No recent reports of development identified for preclinical development in Pancreatic-cancer in USA
- 08 Dec 2014 Medical Marijuana Sciences is now called Viridis Biotech